S1 Data - حسب Guoqing Meng (4669774)

"…Compared to the placebo (PLA) group, mice treated with M07 exhibited significantly lower levels of OVA-specific IgE and IgG1 (<i>P</i> < 0.01). …"

Differential counts of leukocytes in mouse BALF. حسب Guoqing Meng (4669774)

"…Compared to the placebo (PLA) group, mice treated with M07 exhibited significantly lower levels of OVA-specific IgE and IgG1 (<i>P</i> < 0.01). …"

Raw data. حسب Saeedeh Abbasi (9423189)

"…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …"

Data. حسب Saeedeh Abbasi (9423189)

"…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …"

Changes in body weight and glycolipid metabolism in different groups. حسب Shujuan Hu (22656045)

الموضوعات:

Morphological changes of skeletal muscle, fat and liver in each group. حسب Shujuan Hu (22656045)

الموضوعات:

Effects of aerobic exercise on the expression levels of NLRP3 and its related factors in the skeletal muscle of mice. حسب Shujuan Hu (22656045)

الموضوعات:

Potential mechanism of aerobic exercise in regulating glycolipid metabolism of PDM mice. حسب Shujuan Hu (22656045)

الموضوعات:

The expression of irisin, NLRP3 and inflammation-related factors in C2C12 cells. حسب Shujuan Hu (22656045)

الموضوعات:

Flow chart. حسب Shujuan Hu (22656045)

الموضوعات:

Changes of metabolic indexes in the PDM group and DC group. حسب Shujuan Hu (22656045)

الموضوعات:

Sequences of primers used for qRT-PCR. حسب Shujuan Hu (22656045)

الموضوعات:

Supplementary Material for: Focus on the Blind Spot of Stone Disease: Analysis of Lower Urinary Tract Stone Interventions from 2006 to 2020 using German nationwide inpatient data. حسب Herout R. (20352174)

"…Results Total case numbers of therapeutic interventions for lower urinary tract calculi increased from 6,770 in 2006 to 9,037 in 2020 (p<0.001). …"

Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study حسب Klaus G. Parhofer (12280424)

"…LDL cholesterol (LDL-C) changes and factors influencing lipid-lowering therapy (LLT) intensification were assessed after one year. …"

Data Sheet 8_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"

Data Sheet 5_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"

Data Sheet 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"

Data Sheet 7_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"

Data Sheet 3_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"

Data Sheet 6_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…Background<p>Particulate matter pollution (PMP) remains a leading risk factor for lower respiratory infections (LRIs) globally. However, the evolving contributions of household air pollution (HAP) versus ambient particulate matter pollution (APMP) across different development stages remain poorly characterized, hindering targeted intervention strategies.…"